First-in-Human Case of Transfemoral CardiAQ Mitral Valve Implantation

Lars Søndergaard; Ole De Backer; Olaf Franzen; Susanne Holme; Nikolaj Ihlemann; Niels Vejlstrup; Peter B. Hansen; Arshad Quadri

doi:10.1161/circinterventions.115.002135

July 1, 2015Circulation Cardiovascular Interventions

First-in-Human Case of Transfemoral CardiAQ Mitral Valve Implantation

View at Publisher

Ask AI

Bookmark

Share

Structured PICO

P

Population

1 86-year-old male with symptomatic severe mitral regurgitation (grade 3+ to 4) due to mitral annular dilatation and severely restricted posterior mitral leaflet, dilated LV with EF 40%, declined for surgery (STS score 31.9%) and MitraClip.

I

Intervention

Percutaneous transfemoral transcatheter mitral valve implantation (TMVI) using the first-generation CardiAQ valve.

This first-in-human case demonstrates the technical feasibility of transfemoral transcatheter mitral valve implantation using the CardiAQ valve, despite the patient's early mortality from non-valve-related complications.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

First-in-human transfemoral TMVI achieved technical success; leaves open periprocedural SIRS risks for larger prospective evaluation.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Søndergaard et al. (2015) studied this question.

synapsesocial.com/papers/6a83d2692ccfc61f58b063ec https://doi.org/10.1161/circinterventions.115.002135

View at Publisher

Ask AI

Bookmark

Share

First-in-Human Case of Transfemoral CardiAQ Mitral Valve Implantation

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

First-in-Human Case of Transfemoral CardiAQ Mitral Valve Implantation

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading